University of Texas Health Science Center at San Antonio — San Antonio, Texas

Public research footprint of University of Texas Health Science Center at San Antonio, compiled from the ClinicalTrials.gov public registry.

964

Registered studies

245

Active

120

Recruiting now

620

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid… · Metastatic Malignant Solid Neoplasm · Rhabdomyosarcoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT03842228 — Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Texas Health Science Center at San Antonio?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.